Iron oxide magnetic particles
US-2024058449-A1 · Feb 22, 2024 · US
US10016499B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10016499-B2 |
| Application number | US-201615098063-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 13, 2016 |
| Priority date | Mar 15, 2011 |
| Publication date | Jul 10, 2018 |
| Grant date | Jul 10, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides nanoparticles including a metallic core having a length along each axis of from 1 to 100 nanometers and a coating disposed on at least part of the surface of the metallic core, wherein the coating comprises polydopamine, along with methods for making and using such nanoparticles. The metallic core may be gold, silver or iron oxide and the polydopamine coating may have other substances bound to it, such as silver, targeting ligands or antibodies, or other therapeutic or imaging contrast agents. The disclosed nanoparticles can be targeted to cells for treating cancer or bacterial infections, and for use in diagnostic imaging.
Opening claim text (preview).
We claim: 1. A method for treating a bacterial infection comprising administering to a patient infected with bacteria one or more nanoparticles, comprising: (a) a metallic core having a length along each axis of from 1 to 100 nanometers; and (b) a coating disposed on at least part of the surface of the metallic core, wherein the coating comprises polydopamine, wherein one or more antibodies is bound to the coating, optionally further comprising polyethylene glycol, functionalized polyethylene glycol, or a mixture thereof bound to the coating, wherein the metallic core consists essentially of gold and wherein the antibody is an anti-bacterial surface antibody, wherein the anti-bacterial surface antibody is an anti-lipoteichoic acid antibody or an anti-endotoxin antibody, wherein lipoteichoic acid or endotoxin are present on the bacterial surface, wherein the coating of the one or more nanoparticles further comprises silver; and further comprising the step of exposing the nanoparticles to light, whereby the one or more nanoparticles target the bacteria and the bacterial infection is effectively treated.
Boron compounds · CPC title
Nanoparticles · CPC title
the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb · CPC title
Inorganic compounds · CPC title
detecting the surface plasmon resonance of nanostructured metals, e.g. localised surface plasmon resonance · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.